Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Podcast
Biologics, Creams, and the Safety Factor in Vitiligo (Ep. 44)
Vitiligo care is finally breaking free from the old routine of steroids and phototherapy. Biologics like JAK inhibitors are driving impressive repigmentation in trials, while ruxolitinib cream made history as the first FDA-approved topical.
But the real headline is safety. A decade of FDA reports on tacrolimus, pimecrolimus, and ruxolitinib shows mostly mild, local side effects — yet a few rare surprises too, from tacrolimus-linked heart rhythm changes to ruxolitinib cases of anemia and pericarditis. None fatal, none disabling — but proof that “topical” doesn’t mean “risk-free,” especially with long-term or large-area use.
We also explore the essentials: how dosing shapes results, how quickly patients improve, and where these treatments are headed.
By 2026–2028, expect longer-lasting repigmentation, fewer steroids, and more personalized options. Until then: cautious optimism, careful reading of labels, and a close eye on what’s next.
Suggested reading:
- Topical Treatments for Vitiligo: What We Know (and Still Don’t) About Their Safety
- Biologic Therapies for Vitiligo: A New Era of Hope
FAQOther Questions
- What tests for vitiligo should be done?
Before starting vitiligo therapy, several tests may be recommended to ensure an accurate diagnosis and appropriate treatment plan: Physical Examination A thorough physical exa...
- PTSD in Vitiligo?
Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...
- Can chemicals cause vitiligo?
Certain chemicals can trigger vitiligo, leading to a condition known as chemical-induced vitiligo. While clinically and histologically indistinguishable from other types of viti...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.